Related Experiment Video
Updated: Aug 9, 2026
06:24
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
Summary
Managers in sterile services and private healthcare manufacturing share common challenges. Both face staffing issues, resource limits, and must adhere to the
Area of Science:
- Healthcare Management
- Medical Device Manufacturing
- Sterile Processing
Background:
- Sterile services departments and private sector manufacturers face similar operational constraints.
- Both sectors are responsible for supplying sterile health-care products.
Purpose of the Study:
- To highlight the shared challenges and ethical considerations between sterile services management and private healthcare product manufacturing.
- To draw parallels in operational management and regulatory adherence.
Main Methods:
- Comparative analysis of management responsibilities in sterile services and private healthcare manufacturing.
- Review of regulatory frameworks applicable to both sectors, specifically the 'Guide to Good Manufacturing Practice for Sterile Medical Devices & Surgical Products 1981'.
Main Results:
- Identified common issues in staff employment and resource limitation for both groups.
- Confirmed that both sterile services and private manufacturers are subject to the ethical guidelines of the 'Blue Guide'.
Conclusions:
- There are significant overlaps in the managerial and ethical responsibilities of British sterile services departments and private sterile health-care product manufacturers.
- Adherence to the 'Blue Guide' is a critical shared requirement for ensuring product safety and quality in both sectors.
Related Concept Videos
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:26Good Manufacturing Practices
Good Manufacturing Practices (GMP) constitute a foundational set of guidelines that ensure the production of safe, consistent, and high-quality products, particularly in industries such as pharmaceuticals, biotechnology, and food processing. These protocols encompass all aspects of production, from the sourcing of raw materials to the final distribution of the finished product.A core pillar of GMP is stringent hygiene and sanitation across all production environments. This includes routine...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:29Downstream Processing
Downstream processing begins once fermentation is complete and involves a series of steps to recover and purify products such as acids, vitamins, antibiotics, or proteins.Cell HarvestingFor example, for intracellular protein-based products, the first step is harvesting the cells. This is typically achieved using centrifugation or filtration to separate the cells from the liquid phase.Cell Disruption for Intracellular ProductsIf the target product is intracellular, the harvested cells must be...